poisar

Stock

Omada Health, Inc. OMDA

$24.02-1.44%

Overview

OMDA market data

Price History

OMDA price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.35
Diluted earnings per share over the trailing twelve months.
Beta
1.45
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-2.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$10.28 – $26.92
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.5B · P/B 3.98 · P/S 5.27.

Company News

10 captured
JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30Benzinga · Aug 14, 2026, 4:08 PM
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32Benzinga · Aug 14, 2026, 12:52 PM
Baird Maintains Neutral on Omada Health, Raises Price Target to $25Benzinga · Aug 12, 2026, 10:38 AM
BTIG Maintains Buy on Omada Health, Raises Price Target to $35Benzinga · Aug 10, 2026, 9:34 AM
Omada Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY2026 sales guidance above estimates.Benzinga · Aug 7, 2026, 3:36 PM
Omada Health Announces President Wei-Li Shao To Become CEO Effective January 1, 2027, Succeeding Co-Founder Sean Duffy, Who Transitions To Founder And Executive ChairBenzinga · Aug 6, 2026, 8:41 PM
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M EstBenzinga · Aug 6, 2026, 8:12 PM
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M EstimateBenzinga · Aug 6, 2026, 8:05 PM
Barclays Maintains Overweight on Omada Health, Raises Price Target to $25Benzinga · Aug 3, 2026, 12:16 PM
Canaccord Genuity Maintains Buy on Omada Health, Raises Price Target to $28Benzinga · Jul 21, 2026, 11:38 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock